Works matching IS 13520504 AND DT 2015 AND VI 22 AND IP 8

Results: 9

A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 658, doi. 10.1111/jvh.12372
By:
- Tatum, H.;
- Thuluvath, P. J.;
- Lawitz, E.;
- Martorell, C.;
- DeMicco, M.;
- Cohen, S.;
- Rustgi, V.;
- Ravendhran, N.;
- Ghalib, R.;
- Hanson, J.;
- Zamparo, J.;
- Zhao, J.;
- Cooney, E.;
- Treitel, M.;
- Hughes, E.
Publication type:
Article
Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 and PROMISE studies
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 639, doi. 10.1111/jvh.12365
By:
- Scott, J.;
- Gilles, L.;
- Fu, M.;
- Brohan, E.;
- Panter, C.;
- Arbuckle, R.;
- Jessner, W.;
- Beumont, M.
Publication type:
Article
Clinical impact of treatment timing for chronic hepatitis C infection: a decision model.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 630, doi. 10.1111/jvh.12412
By:
- Pho, M. T.;
- Jensen, D. M.;
- Meltzer, D. O.;
- Kim, A. Y.;
- Linas, B. P.
Publication type:
Article
Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 675, doi. 10.1111/jvh.12368
By:
- Lu, L.;
- Yip, B.;
- Trinh, H.;
- Pan, C. Q.;
- Han, S.‐H. B.;
- Wong, C. C.;
- Li, J.;
- Chan, S.;
- Krishnan, G.;
- Nguyen, M. H.
Publication type:
Article
Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 651, doi. 10.1111/jvh.12369
By:
- Halota, W.;
- Ferenci, P.;
- Kozielewicz, D.;
- Dybowska, D.;
- Lisovoder, N.;
- Samira, S.;
- Shalit, I.;
- Ellis, R.;
- Ilan, Y.
Publication type:
Article
Cognitive function and endogenous cytokine levels in children with chronic hepatitis C.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 665, doi. 10.1111/jvh.12373
By:
- Abu Faddan, N. H.;
- Shehata, G. A.;
- Abd Elhafeez, H. A.;
- Mohamed, A. O.;
- Hassan, H. S.;
- Abd El Sameea, F.
Publication type:
Article
HCV: the best cure possible or the best possible cure?
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 627, doi. 10.1111/jvh.12411
By:
- Craxì, L.;
- Cammà, C.;
- Craxì, A.
Publication type:
Article
Role of complement component C4 in treatment response and disease progression in chronic hepatitis C patients.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 671, doi. 10.1111/jvh.12383
By:
- Chowdhury, S. J.;
- Karra, V. K.;
- Bharali, R.;
- Kar, P.
Publication type:
Article
'HepConomics': cost-effective, indeed, but how can we pay for it?
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 682, doi. 10.1111/jvh.12396
By:
- Athanasakis, K.;
- Petrakis, I.;
- Kyriopoulos, J.
Publication type:
Article